In intensive care units around the world, a quiet inequity persists at the intersection of biology and institutional habit: sepsis patients receive antibiotic doses calibrated to a generalized body that does not exist. A new editorial by Dr. Helena Barrasa, Dr. Goiatz Balziskueta, and Prof. Jordi Rello argues that biological sex and gender bias together distort treatment outcomes — leaving women vulnerable to toxicity and men to underdosing. The science of precision medicine has long offered a path forward, yet the will to walk it has lagged behind the knowledge that demands it.
Medical Xpress
· Oct 31, 2025
· health
· 2 min read
High
Sourcing: Verified
Experts call for sex-aware sepsis treatment protocols to address dosing disparities
Sex-based treatment disparities in sepsis care result in differential mortality and morbidity outcomes, with women at higher risk of adverse drug reactions and men at risk of treatment failure.
◉
Health & Medicine
8180 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
CBS News · Aug 21
Nashville hospital drug mix-up leaves 4 patients with severe complications
Four patients at a Nashville hospital received potassium instead of pain medication during routine joint replacement sur…
BBC News · Aug 21 UK warns vulnerable groups to avoid runny eggs amid salmonella outbreakUK health authorities warn vulnerable populations to avoid undercooked eggs at restaurants due to a rapidly expanding sa…
BBC News · Aug 21 Meghan in talks for Netflix's The Gentlemen as she considers return to actingMeghan is in early talks to return to acting with a role in Netflix's The Gentlemen, marking her first significant actin…
The Pharmaceutical Journal · Aug 21 Survey reveals aesthetic goals driving weight-loss medication use over health concernsA UK survey shows 78% of respondents would consider weight-loss medications for weddings and holidays rather than health…
Bias & Framing
⚖
Article advocates for sex-aware sepsis protocols, emphasizing women's overexposure risks and men's underdosing issues, with significant focus on gender inequities in care delivery.
Bias Direction
center-left
Confidence
MED
Problem-solution framing with emphasis on health equity disparities. The article frames standardized dosing as a systemic failure requiring urgent protocol reform, positioning sex/gender-aware medicine as the corrective solution.
overlooked pharmacokinetic differences
compromising outcomes
vulnerable to adverse effects
implicit bias within emergency systems
inequities compound
less likely to receive aggressive interventions
symptom misinterpretation
Pharmaceutical industry perspective on dosing protocol development costs/feasibility
Counterargument that current standardized protocols may reflect evidence-based averages across populations
Implementation challenges or resource constraints in updating clinical protocols
Perspective from clinicians on practical barriers to individualized dosing
Data on actual mortality/morbidity differences attributable to dosing disparities vs. other factors
Discussion of whether sex-based protocols might introduce new inequities or complexity
Geopolitical Impact
🌎
Medical experts advocate sex-aware sepsis treatment protocols to address pharmacokinetic disparities and gender inequities in antibiotic dosing, affecting global ICU care standards.
Escalation Risk
low
Confidence
HIGH
Global
Europe
North America
Healthcare systems worldwide
Shift toward evidence-based medicine challenging standardized protocols; medical institutions gaining influence through advocacy for personalized treatment; potential realignment of pharmaceutical dosing standards globally.
Similar to the 1990s-2000s movement recognizing sex-based differences in cardiovascular disease treatment, which eventually led to FDA guidance on sex-specific drug testing and dosing.
Economic Lens
📈
Medical experts advocate for sex-aware sepsis treatment protocols to address dosing disparities, potentially reducing adverse drug reactions in women and treatment failures in young men, with implications for healthcare costs and clinical outcomes.
Market Signal
mixed
Confidence
MED
Pharmaceutical and biotechnology
Healthcare services and hospitals
Medical device and diagnostic testing
Health insurance and managed care
Clinical research and development
Patients may experience improved treatment outcomes and reduced adverse drug reactions through personalized dosing; however, implementation costs could increase healthcare expenses. Women and young men with sepsis would benefit from more tailored treatment protocols, potentially reducing hospitalizations and mortality-related economic losses.
Regulatory bodies (FDA, EMA) may require sex-stratified pharmacokinetic data in drug trials and approval processes. Healthcare systems may need to update clinical protocols and invest in personalized medicine infrastructure. Potential mandates for gender-disaggregated health outcome reporting and equity audits in emergency departments. Insurance reimbursement models may shift to incentivize precision dosing protocols.